Skip to main content
BKYI
NASDAQ Technology

BIO-key 公布第四季度每股亏损19美分，远低于预期

feedReported by Dow Jones Newswires
Sentiment info
Negative
Importance info
8
Price
$0.59
Mkt Cap
$6.488M
52W Low
$0.509
52W High
$1.97
Market data snapshot near publication time

summarizeSummary

BIO-key International, Inc. 公布第四季度每股亏损19美分。该结果远远低于分析师的共识预期，仅几天前路透社报道称，预计同期每股亏损7美分。巨大的收益缺口表明公司的财务表现低于预期，这对公司来说尤其是小市值公司来说是一个重大负面发展。交易者将密切关注公司关于导致亏损增加的因素以及任何更新的前景的进一步细节。

在该公告发布时，BKYI的交易价格为$0.59，交易所为NASDAQ，所属行业为Technology，市值约为$648.8万。 52周交易区间为$0.51至$1.97。 这则新闻被评估为消极市场情绪，重要性评分为8/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed BKYI - Latest Insights

BKYI
Apr 29, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key International Finalizes 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance
Sentiment: Negative
View Wiseek Article
BKYI
Apr 24, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Stockholders Approve Reverse Stock Split to Address Nasdaq Compliance
Sentiment: Neutral
View Wiseek Article
BKYI
Apr 22, 2026, 4:45 PM EDT
Source: GlobeNewswire
Importance Score:
8
BIO-key Receives Nasdaq Non-Compliance Notice for Delayed 10-K Filing
Sentiment: Negative
View Wiseek Article
BKYI
Apr 20, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Projects 50% H1 Revenue Growth and Profitability Turnaround
Sentiment: Positive
View Wiseek Article
BKYI
Apr 16, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
BIO-key Forecasts 50% H1 Revenue Surge, Projects Positive Net Income
Sentiment: Positive
View Wiseek Article
BKYI
Mar 31, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Reports Strong Cash Position and Positive 2026 Outlook Despite Q4 EPS Miss
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 31, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
BIO-key Reports Q4 Loss of 19 Cents Per Share, Significantly Missing Estimates
Sentiment: Negative
View Wiseek Article
BKYI
Mar 27, 2026, 9:51 AM EDT
Source: Reuters
Importance Score:
7
BIO-Key International Forecasts 7-Cent Loss Per Share, Revenue Expected to Surge 50%
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 16, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
7
BIO-key Files Definitive Proxy for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article
BKYI
Mar 06, 2026, 5:00 PM EST
Filing Type: PRE 14A
Importance Score:
8
BIO-key Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article